{"id":179008,"date":"2026-02-02T07:31:09","date_gmt":"2026-02-02T12:31:09","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=179008"},"modified":"2026-02-02T07:31:12","modified_gmt":"2026-02-02T12:31:12","slug":"sun-pharmaceutical-q3-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sun-pharmaceutical-q3-fy26-earnings-results\/","title":{"rendered":"Sun Pharmaceutical Q3 FY26 Earnings Results"},"content":{"rendered":"\n<p>Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.<\/p>\n\n\n\n<div style=\"height:31px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Q3 FY26 Earnings Results<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue from Operations:<\/strong> \u20b915,520 cr, +13.5% YoY (\u20b913,675 cr in Q3 FY25).<\/li>\n\n\n\n<li><strong>EBITDA:<\/strong> ~\u20b94,948 cr, EBITDA margin ~31.9% (up ~260 bps YoY).<\/li>\n\n\n\n<li><strong>PAT:<\/strong> \u20b93,369 cr, +16.0% YoY (\u20b92,903 cr in Q3 FY25). <\/li>\n\n\n\n<li><strong>Other Key Metrics:<\/strong> PBT \u20b94,227 cr, +21.6% YoY; India Formulations sales \u20b94,998 cr, +16.2% YoY; Emerging Markets\/up 21.6% YoY; Global Innovative Medicines sales US$423 mn. <\/li>\n<\/ul>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Management Commentary &amp; Strategic Decisions<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>MD <strong>Kirti Ganorkar<\/strong> highlighted \u201c<a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachLive\/f98cd836-0498-41d3-835b-bd611455ba9d.pdf\" target=\"_blank\" rel=\"noopener\">well-rounded growth across all businesses<\/a>, led by branded India, emerging markets and global innovative medicines.\u201d <\/li>\n\n\n\n<li><strong>Dividend:<\/strong> Interim dividend of \u20b911 per equity share for FY26 approved; record date Feb 5 2026. <\/li>\n\n\n\n<li><strong>Strategic Moves:<\/strong> Company maintaining focus on specialty and innovative products with broad geographic performance, underpinning medium-term growth; large greenfield facility capex (~\u20b93,000 cr) previously approved via subsidiary to expand manufacturing capacity.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17-839x1024.png\" alt=\"\" class=\"wp-image-179010\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Q2 FY26 Earnings Results<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue from Operations:<\/strong> \u20b914,478 cr, +8.6% to +8.9% YoY. <\/li>\n\n\n\n<li><strong>EBITDA:<\/strong> \u20b94,527 cr, +14.9% YoY; EBITDA margin 31.3%. <\/li>\n\n\n\n<li><strong>PAT:<\/strong> \u20b93,118.95 cr, +2.6% YoY. <\/li>\n\n\n\n<li><strong>Other Key Metrics:<\/strong> India formulations +11% YoY, Emerging markets +10.9% YoY; U.S. sales declined 4.1% in generic segment; R&amp;D spend 5.4% of sales. <\/li>\n<\/ul>\n\n\n\n<div style=\"height:31px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Management Commentary Q2<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Q2 commentary highlighted broad-based sales growth across India, Emerging &amp; RoW markets, and rising contribution from global innovative medicines. <\/li>\n\n\n\n<li>U.S. innovative drugs sales outpaced generics but U.S. generics fell slightly; structural shift in portfolio mix noted.<\/li>\n<\/ul>\n\n\n\n<p>To view the company\u2019s previous earnings and latest concall transcripts,&nbsp;<a href=\"https:\/\/alphastreet.com\/india\/\">click here<\/a>&nbsp; to visit the Alphastreet India news channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":179010,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[10162],"class_list":["post-179008","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-17.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":179344,"url":"https:\/\/alphastreet.com\/india\/mankind-pharma-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":0},"title":"Mankind Pharma Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"February 3, 2026","format":false,"excerpt":"Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Q3 FY26 Earnings Results Revenue from Operations: \u20b93,567 cr, +11.5% YoY (vs \u20b93,200+ cr last year) driven by strong domestic chronic portfolio demand. EBITDA: \u20b9925 cr\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-36.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":178100,"url":"https:\/\/alphastreet.com\/india\/rpg-life-sciences-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":1},"title":"RPG Life Sciences Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"January 28, 2026","format":false,"excerpt":"Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients. Q3 FY26 Earnings Results Revenue from Operations: \u20b9180.03 cr, +4.24% YoY vs \u20b9172.71 cr, \u22120.91% QoQ vs \u20b9181.68 cr. EBITDA: \u20b939.76 cr (PBDIT excl OI), +2% QoQ, margin 22.09% (+61 bps QoQ).\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-96.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":179309,"url":"https:\/\/alphastreet.com\/india\/pg-electroplast-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":2},"title":"PG Electroplast Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"February 3, 2026","format":false,"excerpt":"PG Electroplast Limited (PGEL) is the flagship company of PG Group. While the PG Group had started its journey in 1977, PG Electroplast was formally set up in 2003 and is a leading, diversified Indian Electronic Manufacturing Service provider. It specializes in Original Design Manufacturing (ODM), Original Equipment Manufacturing (OEM)\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":179531,"url":"https:\/\/alphastreet.com\/india\/sheela-foam-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":3},"title":"Sheela Foam Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"February 4, 2026","format":false,"excerpt":"Sheela Foam Limited is a leading player in India\u2019s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. Q3 FY26 Earnings Results Revenue from Operations: \u20b91,074 cr, up 11% YoY from \u20b9967\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":177674,"url":"https:\/\/alphastreet.com\/india\/shyam-metalics-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":4},"title":"Shyam Metalics Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"January 26, 2026","format":false,"excerpt":"Shyam Metalics is primarily engaged in the manufacturing of steel and allied products including pellets, sponge iron, TMT and long products, ferro alloys and generation of power. Q3 FY26 Earnings Results Revenue from Operations: \u20b94,421 Crore, +17.7% YoY, -1.0% QoQ EBITDA: \u20b9539 cr, +6.3% YoY, -11.5% QoQ, operating EBITDA \u20b9487\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Shyam Metalics Q3 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/image-62.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":179313,"url":"https:\/\/alphastreet.com\/india\/paradeep-phosphates-q3-fy26-earnings-results\/","url_meta":{"origin":179008,"position":5},"title":"Paradeep Phosphates Q3 FY26 Earnings Results","author":"Chirag Gupta","date":"February 3, 2026","format":false,"excerpt":"Incorporated in 1981, Paradeep Phosphates Limited is a manufacturer of non-urea fertilizers and India\u2019s second largest private sector phosphatic company. The company is engaged in manufacturing, trading, distribution, and sales of a variety of complex fertilizers such as DAP, three grades of Nitrogen-Phosphorus-Potassium (namely NPK-10, NPK-12, and NP-20), Zypmite, Phospho-gypsum,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179008"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179008\/revisions"}],"predecessor-version":[{"id":179011,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179008\/revisions\/179011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/179010"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}